Pharmaceutics
(May 2023)
RETRACTED: Zhou et al. Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation. <i>Pharmaceutics</i> 2021, <i>13</i>, 330
Shiwei Zhou,
Obinna N. Obianom,
Jiangsheng Huang,
Dong Guo,
Hong Yang,
Qing Li,
Yan Shu
Affiliations
Shiwei Zhou
Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
Obinna N. Obianom
Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
Jiangsheng Huang
Department of Thyroid Surgery, The Second Xiangya Hospital, Central South University, Changsha 410011, China
Dong Guo
Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
Hong Yang
Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 21201, USA
Qing Li
Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
Yan Shu
Department of Clinical Pharmacology, Xiangya Hospital, Central South University, Changsha 410008, China
DOI
https://doi.org/10.3390/pharmaceutics15061623
Journal volume & issue
Vol. 15,
no. 6
Abstract
Read online
The authors and the journal retract the article, ‘Pyrvinium Treatment Confers Hepatic Metabolic Benefits via β-Catenin Downregulation and AMPK Activation’ [...]
Keywords
WeChat QR code
Close
